malondialdehyde has been researched along with leflunomide in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fadillioglu, E; Karaman, A; Tas, E; Turkmen, E; Yilmaz, Z | 1 |
Begec, Z; Demirbilek, S; Ersoy, MO; Fadillioglu, E; Kirimlioglu, H; Ozturk, E; Surucu, M | 1 |
Cecen, S; Demir, EM; Ergin, K; Kose, H; Serter, M; Yildiz, Y | 1 |
Kaptanoglu, B; Kutluana, U; Nart, D; Oruc, N; Ozutemiz, O; Yonetci, N | 1 |
Demircan, M; Fadillioglu, E; Gülsul, C; Karadag, N; Karaman, A; Kirimlioglu, H; Tas, E | 1 |
Fadillioglu, E; Karaman, A; Ozturk, E; Samdancı, E; Surucu, M | 1 |
6 other study(ies) available for malondialdehyde and leflunomide
Article | Year |
---|---|
Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Female; Hepatocytes; Isoxazoles; Leflunomide; Liver; Malondialdehyde; Neutrophil Activation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase | 2006 |
Does leflunomide attenuate the sepsis-induced acute lung injury?
Topics: Acute Lung Injury; Adjuvants, Immunologic; Animals; Disease Models, Animal; Glutathione; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Sepsis; Spectrophotometry; Superoxide Dismutase; Treatment Outcome | 2008 |
Protective effects of leflunomide on intestinal ischemia-reperfusion injury: leflunomide against intestinal ischemia-reperfusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Intestinal Diseases; Intestinal Mucosa; Isoxazoles; Leflunomide; Malondialdehyde; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Treatment Outcome | 2010 |
Leflunomide: is a new oral agent in treatment of acute pancreatitis?
Topics: Administration, Oral; Amylases; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Isoxazoles; Leflunomide; Male; Malondialdehyde; Neutrophil Infiltration; Nitric Oxide; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Pulmonary Edema; Rats; Rats, Wistar; Severity of Illness Index; Taurocholic Acid | 2010 |
Effect of leflunomide on liver regeneration after partial hepatectomy in rats.
Topics: Adjuvants, Immunologic; Animals; Catalase; Disease Models, Animal; Hepatectomy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Liver; Liver Diseases; Liver Regeneration; Malondialdehyde; Nitric Oxide; Oxidative Stress; Peroxidase; Protein Carbonylation; Rats; Rats, Wistar; Treatment Outcome | 2010 |
Protective effect of leflunomide against oxidative intestinal injury in a rodent model of sepsis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Catalase; Cecum; Disease Models, Animal; Intestinal Mucosa; Intestines; Isoxazoles; Leflunomide; Male; Malondialdehyde; Multiple Organ Failure; Nitric Oxide; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase | 2014 |